BCG,BCG+IL-2膀胱灌注预防膀胱癌复发的疗效评价
BCG,BCG and IL-2 intravesical instillation in the prevention of postopcrative recurrence of bladder tumor
-
摘要: 本文对BCG,BCG＋IL－2膀胱灌注预防膀胱癌术后复发的疗效进行了分析,74例膀胱癌分为两组。一组40例单用BCG(150mg),另一组34例BCG(100mg)＋IL－2(20000Iu)。BCG组随访18～72月,平均30.9月,无肿瘤复发率80％(32/40),BCG＋IL－2组随访16～7O月,平均29.4月,无肿瘤复发率88.3％(3O/34),两组比较有显著性(P<0.01)。结果表明,无论单独用BCG或BCG＋IL－2联合应用,疗效都十分肯定,而BCG＋IL－2组更优,可减少BCG用量,毒副反应小。Abstract: Railway Medical College in Xuzhou, Xuzhou 221009For the prevention of tumor recurrence,intravesical instillation of only 150mg BCGwas instituated postoperatively in 40 cases of bladder cancer and intravesical instillationof a combination of 20000 unites of IL-2 and 100mg of BCG in another 34.In the BCGgroup, 80% (32/40) have been free of tumor for a mean time of 30.9 months (follow upranging from 18 to 72 months) and in the combination of BCG and IL-2 group, 88.3%(30/34) have been free of tumor for a mean time of 29.4% months (follwo up rangingfrom 16 to 70 months).Comparing the results of two groups, it is striking (P<0.01).The results revealed that BCG or combination BCG and IL-2 intravesilal instillation inthe prevention of tumor recurrence, which effect were very definited.The later groupwhat is more dominant, it decreased the dose of BCG and the side-effect minor.
-
Key words:
- Bladder neoplasma /
- carcinoma /
- BCG /
- IL-2 /
- Perfusion
-
-
[1] Ibrahiem EH.Ghoneim MA, Nigam V. Prophylactic tera-palmitate and bacillus Calmette-Guerin immunotherapy of recurrent superficial bladder tumors:Preliminary report. J. Urol,1988,140:498 [2] El-Demiry MIM,Smith G. Ritchie AWS. Local immunore-sponses after intravesical BCG treatment of carcinoma in situ. Brit J Urol 1987.60:543 [3] Merguerian PA. Donahue L,Cockett ATK. Intraluminal interleukin 2 and bacillus Calmette-Guerin for treatment of bladder cancer: a preliminary report. J Urol, 1987, 137: 216 [4] Sorosdy MF. Kierum CA Combination immunotherapy of murine, transitional cell cancer using BCG and interferon inducing pyrimidinone. J Uro1.1989.142:1376 [5] Dow AJ. Di-sant Agnese PA. Cockett AT. Empression of blood group precurson T antigen as a prognostic marker for human bladder cancer treated by bacillus Calmette-Guerin and interleukin 2, J Urol, 1989,142:978 [6] 苟欣,肖明朝,何梓铭.BCG +1L-2膀胧内灌注预防膀肤癌 复发的疗效观察.中华泌尿外科杂志,1996.17:91
计量
- 文章访问数: 1074
- HTML全文浏览量: 18
- PDF下载量: 227
下载:
